Nanoagents & Synthetic Formulations Committee

The goal of the Nanoagents and Synthetic Formulations Committee is to provide a comprehensive overview of major trends, developments, and advances in the field of nonviral formulation of gene therapies. The committee covers topics in exosomes, liposomes, targeted assembly, and novel protein and peptide engineering approaches. In addition, the committee’s purview includes novel developments in the areas of nanoparticle self-assembly from natural materials such as proteins, RNA, and carbohydrates.
Full NamePositionOrganizationTerm StartTerm End
Rajagopal Ramesh, PhDChairUniversity of Oklahoma Health Sciences Center6/1/20255/31/20271271
Thomas Neenan, PhDMemberNanite Inc.6/1/20245/31/202749229
Syed Reza, MD, PhDMemberUnlok Development6/1/20255/31/202848004
David Oupicky, PhDMemberUniversity of Nebraska Medical Center6/1/20235/31/20297302
Hamideh Parhiz, PhD, PharmDMemberUniversity of Pennsylvania6/1/20255/31/202829370
Joseph G. Hacia, PhDMemberUniversity of Southern California6/1/20235/31/202921769
Daniel Scherman, PhDMemberFoundation For Rare Diseases6/1/20245/31/20271594
Jonathan D. Finn, PhDMemberBasecamp Research6/1/20265/31/20297663
Roman Bogorad, PhDMemberSouffle Therapeutics6/1/20235/31/202929441
Alexis Stamatikos, PhD/RD, FAHAMemberClemson University6/1/20265/31/2029109071
Paulo Jc LinMemberAcuitas Therapeutics6/1/20265/31/202995644
Danielle GaleStaff LiaisonASGCT6/1/20215/31/204535359